SI1667655T1 - Nova uporaba, farmacevtski pripravki, kot tudi postopek za njihovo proizvodnjo - Google Patents

Nova uporaba, farmacevtski pripravki, kot tudi postopek za njihovo proizvodnjo

Info

Publication number
SI1667655T1
SI1667655T1 SI200431734T SI200431734T SI1667655T1 SI 1667655 T1 SI1667655 T1 SI 1667655T1 SI 200431734 T SI200431734 T SI 200431734T SI 200431734 T SI200431734 T SI 200431734T SI 1667655 T1 SI1667655 T1 SI 1667655T1
Authority
SI
Slovenia
Prior art keywords
production
well
concentrated
pharmaceutical preparations
new use
Prior art date
Application number
SI200431734T
Other languages
English (en)
Inventor
Berthold Roessler
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of SI1667655T1 publication Critical patent/SI1667655T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200431734T 2003-10-01 2004-09-28 Nova uporaba, farmacevtski pripravki, kot tudi postopek za njihovo proizvodnjo SI1667655T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50775003P 2003-10-01 2003-10-01
PCT/US2004/031650 WO2005032515A1 (en) 2003-10-01 2004-09-28 New use, pharmaceutical preparations as well as a process for their production
EP04789095A EP1667655B1 (en) 2003-10-01 2004-09-28 New use, pharmaceutical preparations as well as a process for their production

Publications (1)

Publication Number Publication Date
SI1667655T1 true SI1667655T1 (sl) 2011-10-28

Family

ID=34421657

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431734T SI1667655T1 (sl) 2003-10-01 2004-09-28 Nova uporaba, farmacevtski pripravki, kot tudi postopek za njihovo proizvodnjo

Country Status (13)

Country Link
US (1) US8093230B2 (sl)
EP (1) EP1667655B1 (sl)
JP (2) JP4886517B2 (sl)
AT (1) ATE516014T1 (sl)
CA (1) CA2540537A1 (sl)
CY (1) CY1111960T1 (sl)
DK (1) DK1667655T3 (sl)
ES (1) ES2369776T3 (sl)
HK (1) HK1091146A1 (sl)
PL (1) PL1667655T3 (sl)
PT (1) PT1667655E (sl)
SI (1) SI1667655T1 (sl)
WO (1) WO2005032515A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) * 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US10092312B2 (en) 2013-05-07 2018-10-09 Auxin Surgery Sa Device for chemically assisted dissection
PL3092009T3 (pl) 2014-01-06 2020-03-31 Auxin Surgery Sa Liofilozowane kompozycje mesny
WO2017157670A1 (en) * 2016-03-14 2017-09-21 Auxin Surgery Sa Device, method and formulation for chemically assisted dissection
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
EP0002495B1 (de) * 1977-12-14 1984-02-15 Asta-Werke Aktiengesellschaft Chemische Fabrik Erzeugnisse zur Anwendung in der cytostatischen Therapie
US5204335A (en) 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
ATE63121T1 (de) 1987-03-06 1991-05-15 Asta Pharma Ag Verfahren zur herstellung von ifosfamid mit verbesserten eigenschaften.
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
DE19540132C2 (de) 1995-10-27 2003-04-03 Stada Arzneimittel Ag Ifosfamid-Lyophilisat
US6906047B2 (en) 2001-12-13 2005-06-14 Gensia Sicor Pharmaceuticals, Inc. Aqueous ifosfamide composition
US6613927B1 (en) 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
US20050272698A1 (en) * 2002-09-05 2005-12-08 Daftary Gautam V Liquid stable composition of oxazaphosphorine with mesna
US7199111B2 (en) 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations

Also Published As

Publication number Publication date
EP1667655A1 (en) 2006-06-14
JP2007507506A (ja) 2007-03-29
US20050124589A1 (en) 2005-06-09
US8093230B2 (en) 2012-01-10
CA2540537A1 (en) 2005-04-14
ATE516014T1 (de) 2011-07-15
JP2011137048A (ja) 2011-07-14
JP4886517B2 (ja) 2012-02-29
CY1111960T1 (el) 2015-11-04
HK1091146A1 (en) 2007-01-12
DK1667655T3 (da) 2011-10-24
PT1667655E (pt) 2011-08-18
ES2369776T3 (es) 2011-12-05
PL1667655T3 (pl) 2012-05-31
EP1667655B1 (en) 2011-07-13
WO2005032515A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
GT200500257A (es) Procedimiento para producir derivados de amina opticamente activos
UY28033A1 (es) Complejos de carbohidrato de hierro acuosos, su produccion y medicamentos que los contienen
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
GEP20053650B (en) Disinfectant Solution Based on Sodium Hypochlorite, and Process for Preparing It
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
SI1594885T1 (sl) Zdravilo za inhibiranje rasti tumorjev
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.
NO20030073L (no) Medikamentleveringssystem for medikamenter som er lite vannopplöselige
MY139643A (en) Vinflunine pharmaceutical composition for parenteral administration, preparation process and use thereof.
PT1292303E (pt) Formulacao farmaceutica estavel compreendendo modificacao de torsemida ii
PL357999A1 (en) Lhrh-antagonists, production and use thereof as medicament
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA05005919A (es) Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.